nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.185	0.324	CbGbCtD
Sparfloxacin—ABCB1—Lisinopril—systemic scleroderma	0.103	0.179	CbGbCtD
Sparfloxacin—ABCB1—Captopril—systemic scleroderma	0.0768	0.134	CbGbCtD
Sparfloxacin—ABCC2—Methotrexate—systemic scleroderma	0.0744	0.13	CbGbCtD
Sparfloxacin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0605	0.106	CbGbCtD
Sparfloxacin—ABCB1—Prednisone—systemic scleroderma	0.0483	0.0845	CbGbCtD
Sparfloxacin—ABCB1—Methotrexate—systemic scleroderma	0.0242	0.0424	CbGbCtD
Sparfloxacin—TOP2A—Methyltestosterone—Prednisone—systemic scleroderma	0.000948	1	CbGdCrCtD
Sparfloxacin—Dyspepsia—Leflunomide—systemic scleroderma	0.000246	0.000577	CcSEcCtD
Sparfloxacin—Pancreatitis—Prednisone—systemic scleroderma	0.000246	0.000577	CcSEcCtD
Sparfloxacin—Vomiting—Mometasone—systemic scleroderma	0.000246	0.000576	CcSEcCtD
Sparfloxacin—Dry mouth—Lisinopril—systemic scleroderma	0.000245	0.000575	CcSEcCtD
Sparfloxacin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000244	0.000572	CcSEcCtD
Sparfloxacin—Rash—Mometasone—systemic scleroderma	0.000244	0.000571	CcSEcCtD
Sparfloxacin—Asthenia—Captopril—systemic scleroderma	0.000244	0.000571	CcSEcCtD
Sparfloxacin—Dermatitis—Mometasone—systemic scleroderma	0.000244	0.000571	CcSEcCtD
Sparfloxacin—Decreased appetite—Leflunomide—systemic scleroderma	0.000243	0.00057	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000243	0.00057	CcSEcCtD
Sparfloxacin—Osteoarthritis—Methotrexate—systemic scleroderma	0.000243	0.000569	CcSEcCtD
Sparfloxacin—Confusional state—Lisinopril—systemic scleroderma	0.000242	0.000568	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000242	0.000568	CcSEcCtD
Sparfloxacin—Headache—Mometasone—systemic scleroderma	0.000242	0.000568	CcSEcCtD
Sparfloxacin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000567	CcSEcCtD
Sparfloxacin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000241	0.000566	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00024	0.000563	CcSEcCtD
Sparfloxacin—Pruritus—Captopril—systemic scleroderma	0.00024	0.000563	CcSEcCtD
Sparfloxacin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00024	0.000562	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00024	0.000561	CcSEcCtD
Sparfloxacin—Pain—Leflunomide—systemic scleroderma	0.000239	0.000561	CcSEcCtD
Sparfloxacin—Constipation—Leflunomide—systemic scleroderma	0.000239	0.000561	CcSEcCtD
Sparfloxacin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000238	0.000558	CcSEcCtD
Sparfloxacin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000237	0.000556	CcSEcCtD
Sparfloxacin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000237	0.000556	CcSEcCtD
Sparfloxacin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000553	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000235	0.000552	CcSEcCtD
Sparfloxacin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000235	0.000551	CcSEcCtD
Sparfloxacin—Tachycardia—Lisinopril—systemic scleroderma	0.000235	0.00055	CcSEcCtD
Sparfloxacin—Abdominal pain—Azathioprine—systemic scleroderma	0.000234	0.000549	CcSEcCtD
Sparfloxacin—Body temperature increased—Azathioprine—systemic scleroderma	0.000234	0.000549	CcSEcCtD
Sparfloxacin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000233	0.000546	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000232	0.000545	CcSEcCtD
Sparfloxacin—Diarrhoea—Captopril—systemic scleroderma	0.000232	0.000544	CcSEcCtD
Sparfloxacin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000232	0.000544	CcSEcCtD
Sparfloxacin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000543	CcSEcCtD
Sparfloxacin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000231	0.00054	CcSEcCtD
Sparfloxacin—Mood swings—Methotrexate—systemic scleroderma	0.00023	0.000539	CcSEcCtD
Sparfloxacin—Nausea—Mometasone—systemic scleroderma	0.00023	0.000538	CcSEcCtD
Sparfloxacin—Anorexia—Lisinopril—systemic scleroderma	0.000229	0.000537	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000229	0.000536	CcSEcCtD
Sparfloxacin—Ataxia—Methotrexate—systemic scleroderma	0.000228	0.000535	CcSEcCtD
Sparfloxacin—Pain—Mycophenolic acid—systemic scleroderma	0.000228	0.000535	CcSEcCtD
Sparfloxacin—Constipation—Mycophenolic acid—systemic scleroderma	0.000228	0.000535	CcSEcCtD
Sparfloxacin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000535	CcSEcCtD
Sparfloxacin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000528	CcSEcCtD
Sparfloxacin—Dizziness—Captopril—systemic scleroderma	0.000225	0.000526	CcSEcCtD
Sparfloxacin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000524	CcSEcCtD
Sparfloxacin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000522	CcSEcCtD
Sparfloxacin—Urticaria—Leflunomide—systemic scleroderma	0.000222	0.000521	CcSEcCtD
Sparfloxacin—Abdominal pain—Leflunomide—systemic scleroderma	0.000221	0.000518	CcSEcCtD
Sparfloxacin—Body temperature increased—Leflunomide—systemic scleroderma	0.000221	0.000518	CcSEcCtD
Sparfloxacin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00022	0.000516	CcSEcCtD
Sparfloxacin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000515	CcSEcCtD
Sparfloxacin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000515	CcSEcCtD
Sparfloxacin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000515	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000219	0.000513	CcSEcCtD
Sparfloxacin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000513	CcSEcCtD
Sparfloxacin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000219	0.000512	CcSEcCtD
Sparfloxacin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000218	0.000512	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000218	0.000512	CcSEcCtD
Sparfloxacin—Insomnia—Lisinopril—systemic scleroderma	0.000218	0.00051	CcSEcCtD
Sparfloxacin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000509	CcSEcCtD
Sparfloxacin—Paraesthesia—Lisinopril—systemic scleroderma	0.000216	0.000506	CcSEcCtD
Sparfloxacin—Vomiting—Captopril—systemic scleroderma	0.000216	0.000506	CcSEcCtD
Sparfloxacin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000504	CcSEcCtD
Sparfloxacin—Dyspnoea—Lisinopril—systemic scleroderma	0.000214	0.000502	CcSEcCtD
Sparfloxacin—Rash—Captopril—systemic scleroderma	0.000214	0.000502	CcSEcCtD
Sparfloxacin—Dermatitis—Captopril—systemic scleroderma	0.000214	0.000501	CcSEcCtD
Sparfloxacin—Somnolence—Lisinopril—systemic scleroderma	0.000214	0.000501	CcSEcCtD
Sparfloxacin—Headache—Captopril—systemic scleroderma	0.000213	0.000498	CcSEcCtD
Sparfloxacin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000498	CcSEcCtD
Sparfloxacin—Dyspepsia—Lisinopril—systemic scleroderma	0.000212	0.000496	CcSEcCtD
Sparfloxacin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000211	0.000495	CcSEcCtD
Sparfloxacin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000211	0.000495	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000494	CcSEcCtD
Sparfloxacin—Asthma—Methotrexate—systemic scleroderma	0.00021	0.000492	CcSEcCtD
Sparfloxacin—Decreased appetite—Lisinopril—systemic scleroderma	0.000209	0.00049	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000483	CcSEcCtD
Sparfloxacin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000206	0.000483	CcSEcCtD
Sparfloxacin—Pancreatitis—Methotrexate—systemic scleroderma	0.000206	0.000482	CcSEcCtD
Sparfloxacin—Constipation—Lisinopril—systemic scleroderma	0.000206	0.000482	CcSEcCtD
Sparfloxacin—Pain—Lisinopril—systemic scleroderma	0.000206	0.000482	CcSEcCtD
Sparfloxacin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000482	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000477	CcSEcCtD
Sparfloxacin—Diarrhoea—Azathioprine—systemic scleroderma	0.000203	0.000475	CcSEcCtD
Sparfloxacin—Haemoglobin—Prednisone—systemic scleroderma	0.000202	0.000473	CcSEcCtD
Sparfloxacin—Nausea—Captopril—systemic scleroderma	0.000202	0.000473	CcSEcCtD
Sparfloxacin—Haemorrhage—Prednisone—systemic scleroderma	0.000201	0.000471	CcSEcCtD
Sparfloxacin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000471	CcSEcCtD
Sparfloxacin—Asthenia—Leflunomide—systemic scleroderma	0.000201	0.000471	CcSEcCtD
Sparfloxacin—Hallucination—Prednisone—systemic scleroderma	0.0002	0.000469	CcSEcCtD
Sparfloxacin—Pancytopenia—Methotrexate—systemic scleroderma	0.000199	0.000467	CcSEcCtD
Sparfloxacin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000198	0.000464	CcSEcCtD
Sparfloxacin—Pruritus—Leflunomide—systemic scleroderma	0.000198	0.000464	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000197	0.000461	CcSEcCtD
Sparfloxacin—Dysuria—Methotrexate—systemic scleroderma	0.000196	0.00046	CcSEcCtD
Sparfloxacin—Dizziness—Azathioprine—systemic scleroderma	0.000196	0.000459	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000192	0.00045	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000192	0.000449	CcSEcCtD
Sparfloxacin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000192	0.000449	CcSEcCtD
Sparfloxacin—Diarrhoea—Leflunomide—systemic scleroderma	0.000191	0.000449	CcSEcCtD
Sparfloxacin—Urticaria—Lisinopril—systemic scleroderma	0.000191	0.000448	CcSEcCtD
Sparfloxacin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000447	CcSEcCtD
Sparfloxacin—Abdominal pain—Lisinopril—systemic scleroderma	0.00019	0.000445	CcSEcCtD
Sparfloxacin—Body temperature increased—Lisinopril—systemic scleroderma	0.00019	0.000445	CcSEcCtD
Sparfloxacin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000189	0.000443	CcSEcCtD
Sparfloxacin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000189	0.000443	CcSEcCtD
Sparfloxacin—Vomiting—Azathioprine—systemic scleroderma	0.000188	0.000442	CcSEcCtD
Sparfloxacin—Pneumonia—Methotrexate—systemic scleroderma	0.000188	0.000441	CcSEcCtD
Sparfloxacin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000188	0.00044	CcSEcCtD
Sparfloxacin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000439	CcSEcCtD
Sparfloxacin—Rash—Azathioprine—systemic scleroderma	0.000187	0.000438	CcSEcCtD
Sparfloxacin—Dermatitis—Azathioprine—systemic scleroderma	0.000187	0.000437	CcSEcCtD
Sparfloxacin—Headache—Azathioprine—systemic scleroderma	0.000186	0.000435	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000186	0.000435	CcSEcCtD
Sparfloxacin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000435	CcSEcCtD
Sparfloxacin—Dizziness—Leflunomide—systemic scleroderma	0.000185	0.000434	CcSEcCtD
Sparfloxacin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000183	0.000429	CcSEcCtD
Sparfloxacin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000183	0.000428	CcSEcCtD
Sparfloxacin—Stomatitis—Methotrexate—systemic scleroderma	0.000182	0.000427	CcSEcCtD
Sparfloxacin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000182	0.000426	CcSEcCtD
Sparfloxacin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000422	CcSEcCtD
Sparfloxacin—Pain—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000422	CcSEcCtD
Sparfloxacin—Arrhythmia—Prednisone—systemic scleroderma	0.00018	0.000421	CcSEcCtD
Sparfloxacin—Sweating—Methotrexate—systemic scleroderma	0.000179	0.00042	CcSEcCtD
Sparfloxacin—Haematuria—Methotrexate—systemic scleroderma	0.000178	0.000418	CcSEcCtD
Sparfloxacin—Vomiting—Leflunomide—systemic scleroderma	0.000178	0.000417	CcSEcCtD
Sparfloxacin—Alopecia—Prednisone—systemic scleroderma	0.000178	0.000416	CcSEcCtD
Sparfloxacin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000177	0.000415	CcSEcCtD
Sparfloxacin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000177	0.000414	CcSEcCtD
Sparfloxacin—Epistaxis—Methotrexate—systemic scleroderma	0.000177	0.000414	CcSEcCtD
Sparfloxacin—Rash—Leflunomide—systemic scleroderma	0.000176	0.000413	CcSEcCtD
Sparfloxacin—Dermatitis—Leflunomide—systemic scleroderma	0.000176	0.000413	CcSEcCtD
Sparfloxacin—Nausea—Azathioprine—systemic scleroderma	0.000176	0.000412	CcSEcCtD
Sparfloxacin—Headache—Leflunomide—systemic scleroderma	0.000175	0.000411	CcSEcCtD
Sparfloxacin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000175	0.000409	CcSEcCtD
Sparfloxacin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000407	CcSEcCtD
Sparfloxacin—Asthenia—Lisinopril—systemic scleroderma	0.000173	0.000404	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000404	CcSEcCtD
Sparfloxacin—Pruritus—Lisinopril—systemic scleroderma	0.00017	0.000399	CcSEcCtD
Sparfloxacin—Vomiting—Mycophenolic acid—systemic scleroderma	0.00017	0.000398	CcSEcCtD
Sparfloxacin—Haemoglobin—Methotrexate—systemic scleroderma	0.000169	0.000396	CcSEcCtD
Sparfloxacin—Rash—Mycophenolic acid—systemic scleroderma	0.000168	0.000394	CcSEcCtD
Sparfloxacin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000168	0.000394	CcSEcCtD
Sparfloxacin—Hepatitis—Methotrexate—systemic scleroderma	0.000168	0.000394	CcSEcCtD
Sparfloxacin—Haemorrhage—Methotrexate—systemic scleroderma	0.000168	0.000394	CcSEcCtD
Sparfloxacin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000392	CcSEcCtD
Sparfloxacin—Headache—Mycophenolic acid—systemic scleroderma	0.000167	0.000392	CcSEcCtD
Sparfloxacin—Pharyngitis—Methotrexate—systemic scleroderma	0.000167	0.000391	CcSEcCtD
Sparfloxacin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000167	0.00039	CcSEcCtD
Sparfloxacin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000167	0.00039	CcSEcCtD
Sparfloxacin—Nausea—Leflunomide—systemic scleroderma	0.000166	0.00039	CcSEcCtD
Sparfloxacin—Diarrhoea—Lisinopril—systemic scleroderma	0.000165	0.000386	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000162	0.00038	CcSEcCtD
Sparfloxacin—Agitation—Prednisone—systemic scleroderma	0.000161	0.000377	CcSEcCtD
Sparfloxacin—Angioedema—Prednisone—systemic scleroderma	0.00016	0.000375	CcSEcCtD
Sparfloxacin—Dizziness—Lisinopril—systemic scleroderma	0.000159	0.000373	CcSEcCtD
Sparfloxacin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000159	0.000372	CcSEcCtD
Sparfloxacin—Nausea—Mycophenolic acid—systemic scleroderma	0.000159	0.000372	CcSEcCtD
Sparfloxacin—Malaise—Prednisone—systemic scleroderma	0.000158	0.00037	CcSEcCtD
Sparfloxacin—Vertigo—Prednisone—systemic scleroderma	0.000157	0.000368	CcSEcCtD
Sparfloxacin—Tinnitus—Methotrexate—systemic scleroderma	0.000157	0.000367	CcSEcCtD
Sparfloxacin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000364	CcSEcCtD
Sparfloxacin—Vomiting—Lisinopril—systemic scleroderma	0.000153	0.000358	CcSEcCtD
Sparfloxacin—Rash—Lisinopril—systemic scleroderma	0.000152	0.000355	CcSEcCtD
Sparfloxacin—Convulsion—Prednisone—systemic scleroderma	0.000152	0.000355	CcSEcCtD
Sparfloxacin—Dermatitis—Lisinopril—systemic scleroderma	0.000151	0.000355	CcSEcCtD
Sparfloxacin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000354	CcSEcCtD
Sparfloxacin—Hypertension—Prednisone—systemic scleroderma	0.000151	0.000354	CcSEcCtD
Sparfloxacin—Chills—Methotrexate—systemic scleroderma	0.000151	0.000353	CcSEcCtD
Sparfloxacin—Headache—Lisinopril—systemic scleroderma	0.000151	0.000353	CcSEcCtD
Sparfloxacin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000349	CcSEcCtD
Sparfloxacin—Arthralgia—Prednisone—systemic scleroderma	0.000149	0.000349	CcSEcCtD
Sparfloxacin—Myalgia—Prednisone—systemic scleroderma	0.000149	0.000349	CcSEcCtD
Sparfloxacin—Anxiety—Prednisone—systemic scleroderma	0.000148	0.000348	CcSEcCtD
Sparfloxacin—Alopecia—Methotrexate—systemic scleroderma	0.000148	0.000348	CcSEcCtD
Sparfloxacin—Discomfort—Prednisone—systemic scleroderma	0.000147	0.000345	CcSEcCtD
Sparfloxacin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000338	CcSEcCtD
Sparfloxacin—Dysgeusia—Methotrexate—systemic scleroderma	0.000143	0.000336	CcSEcCtD
Sparfloxacin—Nausea—Lisinopril—systemic scleroderma	0.000143	0.000335	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000143	0.000335	CcSEcCtD
Sparfloxacin—Back pain—Methotrexate—systemic scleroderma	0.000141	0.000331	CcSEcCtD
Sparfloxacin—Tachycardia—Prednisone—systemic scleroderma	0.000139	0.000327	CcSEcCtD
Sparfloxacin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000326	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000138	0.000324	CcSEcCtD
Sparfloxacin—Anorexia—Prednisone—systemic scleroderma	0.000136	0.000319	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000136	0.000318	CcSEcCtD
Sparfloxacin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000314	CcSEcCtD
Sparfloxacin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000311	CcSEcCtD
Sparfloxacin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000311	CcSEcCtD
Sparfloxacin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000309	CcSEcCtD
Sparfloxacin—Malaise—Methotrexate—systemic scleroderma	0.000132	0.000309	CcSEcCtD
Sparfloxacin—Vertigo—Methotrexate—systemic scleroderma	0.000131	0.000308	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00013	0.000305	CcSEcCtD
Sparfloxacin—Insomnia—Prednisone—systemic scleroderma	0.000129	0.000303	CcSEcCtD
Sparfloxacin—Paraesthesia—Prednisone—systemic scleroderma	0.000128	0.000301	CcSEcCtD
Sparfloxacin—Cough—Methotrexate—systemic scleroderma	0.000128	0.000299	CcSEcCtD
Sparfloxacin—Convulsion—Methotrexate—systemic scleroderma	0.000127	0.000297	CcSEcCtD
Sparfloxacin—Dyspepsia—Prednisone—systemic scleroderma	0.000126	0.000295	CcSEcCtD
Sparfloxacin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000293	CcSEcCtD
Sparfloxacin—Arthralgia—Methotrexate—systemic scleroderma	0.000125	0.000292	CcSEcCtD
Sparfloxacin—Chest pain—Methotrexate—systemic scleroderma	0.000125	0.000292	CcSEcCtD
Sparfloxacin—Myalgia—Methotrexate—systemic scleroderma	0.000125	0.000292	CcSEcCtD
Sparfloxacin—Decreased appetite—Prednisone—systemic scleroderma	0.000124	0.000291	CcSEcCtD
Sparfloxacin—Discomfort—Methotrexate—systemic scleroderma	0.000123	0.000288	CcSEcCtD
Sparfloxacin—Constipation—Prednisone—systemic scleroderma	0.000122	0.000286	CcSEcCtD
Sparfloxacin—Confusional state—Methotrexate—systemic scleroderma	0.00012	0.000282	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000119	0.00028	CcSEcCtD
Sparfloxacin—Feeling abnormal—Prednisone—systemic scleroderma	0.000118	0.000276	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000117	0.000274	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000117	0.000274	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000115	0.00027	CcSEcCtD
Sparfloxacin—Anorexia—Methotrexate—systemic scleroderma	0.000114	0.000267	CcSEcCtD
Sparfloxacin—Urticaria—Prednisone—systemic scleroderma	0.000113	0.000266	CcSEcCtD
Sparfloxacin—Abdominal pain—Prednisone—systemic scleroderma	0.000113	0.000265	CcSEcCtD
Sparfloxacin—Body temperature increased—Prednisone—systemic scleroderma	0.000113	0.000265	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000109	0.000255	CcSEcCtD
Sparfloxacin—Insomnia—Methotrexate—systemic scleroderma	0.000108	0.000253	CcSEcCtD
Sparfloxacin—Paraesthesia—Methotrexate—systemic scleroderma	0.000107	0.000251	CcSEcCtD
Sparfloxacin—Dyspnoea—Methotrexate—systemic scleroderma	0.000106	0.000249	CcSEcCtD
Sparfloxacin—Somnolence—Methotrexate—systemic scleroderma	0.000106	0.000249	CcSEcCtD
Sparfloxacin—Hypersensitivity—Prednisone—systemic scleroderma	0.000105	0.000247	CcSEcCtD
Sparfloxacin—Dyspepsia—Methotrexate—systemic scleroderma	0.000105	0.000246	CcSEcCtD
Sparfloxacin—Decreased appetite—Methotrexate—systemic scleroderma	0.000104	0.000243	CcSEcCtD
Sparfloxacin—Asthenia—Prednisone—systemic scleroderma	0.000102	0.00024	CcSEcCtD
Sparfloxacin—Pain—Methotrexate—systemic scleroderma	0.000102	0.000239	CcSEcCtD
Sparfloxacin—Pruritus—Prednisone—systemic scleroderma	0.000101	0.000237	CcSEcCtD
Sparfloxacin—Feeling abnormal—Methotrexate—systemic scleroderma	9.84e-05	0.00023	CcSEcCtD
Sparfloxacin—Diarrhoea—Prednisone—systemic scleroderma	9.77e-05	0.000229	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Methotrexate—systemic scleroderma	9.76e-05	0.000229	CcSEcCtD
Sparfloxacin—Urticaria—Methotrexate—systemic scleroderma	9.48e-05	0.000222	CcSEcCtD
Sparfloxacin—Dizziness—Prednisone—systemic scleroderma	9.44e-05	0.000221	CcSEcCtD
Sparfloxacin—Body temperature increased—Methotrexate—systemic scleroderma	9.44e-05	0.000221	CcSEcCtD
Sparfloxacin—Abdominal pain—Methotrexate—systemic scleroderma	9.44e-05	0.000221	CcSEcCtD
Sparfloxacin—Vomiting—Prednisone—systemic scleroderma	9.08e-05	0.000213	CcSEcCtD
Sparfloxacin—Rash—Prednisone—systemic scleroderma	9.01e-05	0.000211	CcSEcCtD
Sparfloxacin—Dermatitis—Prednisone—systemic scleroderma	9e-05	0.000211	CcSEcCtD
Sparfloxacin—Headache—Prednisone—systemic scleroderma	8.95e-05	0.00021	CcSEcCtD
Sparfloxacin—Hypersensitivity—Methotrexate—systemic scleroderma	8.79e-05	0.000206	CcSEcCtD
Sparfloxacin—Asthenia—Methotrexate—systemic scleroderma	8.56e-05	0.000201	CcSEcCtD
Sparfloxacin—Nausea—Prednisone—systemic scleroderma	8.48e-05	0.000199	CcSEcCtD
Sparfloxacin—Pruritus—Methotrexate—systemic scleroderma	8.45e-05	0.000198	CcSEcCtD
Sparfloxacin—Diarrhoea—Methotrexate—systemic scleroderma	8.17e-05	0.000191	CcSEcCtD
Sparfloxacin—Dizziness—Methotrexate—systemic scleroderma	7.89e-05	0.000185	CcSEcCtD
Sparfloxacin—Vomiting—Methotrexate—systemic scleroderma	7.59e-05	0.000178	CcSEcCtD
Sparfloxacin—Rash—Methotrexate—systemic scleroderma	7.53e-05	0.000176	CcSEcCtD
Sparfloxacin—Dermatitis—Methotrexate—systemic scleroderma	7.52e-05	0.000176	CcSEcCtD
Sparfloxacin—Headache—Methotrexate—systemic scleroderma	7.48e-05	0.000175	CcSEcCtD
Sparfloxacin—Nausea—Methotrexate—systemic scleroderma	7.09e-05	0.000166	CcSEcCtD
